Volume 4 Issue 2
Apr.  2013
Turn off MathJax
Article Contents
Ji-xin ZOU, Zong-ming LIU, Wei LIANG, Huan GUAN, Lei JIN, Rong ZHANG, Yu-rong LIU, Ding-xi LIU, Lin ZHAO, Shu-gang WANG. Corticosteroid Therapy in the Initial Cases of Vogt-Koyanagi-Harada Disease[J]. Medical Journal of Peking Union Medical College Hospital, 2013, 4(2): 138-140. doi: 10.3969/j.issn.1674-9081.2013.02.011
Citation: Ji-xin ZOU, Zong-ming LIU, Wei LIANG, Huan GUAN, Lei JIN, Rong ZHANG, Yu-rong LIU, Ding-xi LIU, Lin ZHAO, Shu-gang WANG. Corticosteroid Therapy in the Initial Cases of Vogt-Koyanagi-Harada Disease[J]. Medical Journal of Peking Union Medical College Hospital, 2013, 4(2): 138-140. doi: 10.3969/j.issn.1674-9081.2013.02.011

Corticosteroid Therapy in the Initial Cases of Vogt-Koyanagi-Harada Disease

doi: 10.3969/j.issn.1674-9081.2013.02.011
More Information
  • Corresponding author: ZOU Ji-xin Tel: 0411-86525401, E-mail:zoujixin881@yahoo.com.cn
  • Received Date: 2013-02-26
  • Publish Date: 2013-04-30
  •   Objective  To observe the application and effectiveness of corticosteroid therapy for the initial cases of Vogt-Koyanagi-Harada disease (VKH).  Methods  Totally 21 VKH cases (42 eyes) from January 2008 to January 2012 in our hospital with initial onset and duration within a week were administered with prednisone of 120-140 mg/d at early morning. The dosage was reduced 20 mg every 3 to 5 days based on the condition improved and reduced 10 mg every 5 days when the dosage reached 80 mg/d, then reduced 5 mg every week from 60 mg/d. When the dose reduced to 15 mg/d, it was maintained for 1-2 months. After that the dose should be gradually reduced by 5 mg per week until zero.  Results  One day after treatment, headache disappeared and visual acuity improved in all patients. On the third day, the visual acuity improved significantly and retinal detachment improved remarkably. On the seventh day, there were 36 eyes (85.7%) with visual acuity ≥ 0.5 and retinal detachments disappeared in all eyes. One month later, the visual acuity returned the optimal levels before the onset in all patients. No serious corticosteroid complications occurred during the treatment. During the 12to 36month follow-up, no recurrence was noted.  Conclusion  Initial treatment with high-dose corticosteroids followed by prolonged corticosteroid therapy can effectively control the VKH.
  • loading
  • [1] 杨培增, 王红, 周红颜, 等. Vogt-Koyanagi-Harada综合征的临床表现及诊断[J].中华眼科杂志, 2002, 38:736-739. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyk200212009
    [2] 王梦华, 侯习武, 魏丽萍, 等. Vogt-小柳-原田综合征的临床治疗[J].中国实用眼科杂志, 2011, 29:1283-1286. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgsyykzz201112021
    [3] 杨培增, 李绍珍.葡萄膜炎[M].北京:人民卫生出版社, 1998:317-324.
    [4] 张美芬, 刘勤, 闵寒毅, 等. Vogt-Koyanagi-Harada综合征的治疗与预后[J].中华眼科杂志, 2002, 38:200-203. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyk200204003
    [5] Pan D, Hirose T. Vogt-Koyanagi-Harada syndrome:review of clinical features[J]. Semin Ophthalmol, 2011, 26:312-315. doi:  10.3109/08820538.2011.588654
    [6] Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome[J]. Surv Ophthalmol, 1995, 39:265-292. doi:  10.1016/S0039-6257(05)80105-5
    [7] Read RW, Yu F, Accorinti M, et al. Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease[J]. Am J Ophthalmol, 2006, 142:119-124. doi:  10.1016/j.ajo.2006.02.049
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)

    Article Metrics

    Article views (127) PDF downloads(4) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return